IVD China Insight Report 2024

China’s IVD market is at a turning point. What was once one of the fastest-growing diagnostics markets globally is now facing contraction, shaped by volume-based procurement (VBP), DRG reforms, and the assertive rise of domestic manufacturers. Our latest Clearstate China IVD Market Insight Report 2024 takes a closer look at how these forces are redefining the competitive landscape — and where the opportunities still lie.

Download

Fragmented scale

130,000+ labs nationwide, but fewer than 5,000 NABL-accredited

Urban–rural imbalance

Urban–rural imbalance: 65% of the population lives outside cities, yet advanced diagnostics remain concentrated in metros.

Consolidation effect

4–5 national lab networks already control ~35% of urban diagnostic volumes.

Growth hotspots

Molecular diagnostics (+11% CAGR) and tissue diagnostics (+14% CAGR) are set to outpace the market.

Hub-and-spoke expansion

Organized lab networks are driving digital adoption, home collection, and access to smaller towns.